The Penn Difference
Why Patients Choose Penn Medicine
Penn Medicine's pancreas and islet cell transplant programs are leading health care beyond the limits of conventional medicine by offering patients more options to improve their lives every day. Patients who choose Penn for their transplant have access to the most advanced care available.
The pancreas and islet cell transplant programs at Penn Medicine, part of the Penn Transplant Institute's multi-organ transplant center at the Hospital of the University of Pennsylvania, have established a national reputation with a number of noteworthy attributes including:
- The first program in the region to offer pancreas transplant as treatment for type 1 diabetes.
- One of the leading transplant centers in the world researching islet cell transplantation.
- Membership in the Clinical Islet Transplantation Consortium funded by the National Institutes of Health.
- Participation in a number of clinical trials for islet transplantation.
- Provides consulting and training services for other medical professionals around the world.
- Recognized by both peers and consumers in Best Doctors in America, Philadelphia magazine's “Top Docs” and America's Top Doctors.
- Membership in the United Network for Organ Sharing (UNOS) and certified as a Medicare Center for pancreas transplantation.
- Partners with Gift of Life, the regional organ procurement organization and the largest organ procurement organization in the country.
- Supports active research programs that put Penn at the forefront of new developments in pancreas transplantation.